EFFECT OF TREATMENT OF HYPERURICEMIA WITH FEBUXOSTAT IN HYPERTENSIVE PATIENTS WITH CHRONIC HEART FAILURE AND CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Naka, T. [1 ]
Sumiyoshi, A. [2 ]
Ando, T. [2 ]
Shibuya, M. [2 ]
Masuyama, T. [2 ]
机构：
[1] Kaizuka City Hosp, Dept Internal Med, Kaizuka, Japan
[2] Hyogo Coll Med, Dept Internal Med, Cardiovasc Div, Nishinomiya, Hyogo, Japan
来源：
CARDIOLOGY | 2015年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
135
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [1] The Efficacy and Safety of Febuxostat for Hyperuricemia in Hypertensive Patients with Chronic Heart Failure and Chronic Kidney Disease
    Naka, Toshio
    Andou, Tomotaka
    Masuyama, Tohru
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S194 - S194
  • [2] Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
    Akimoto, Tetsu
    Morishita, Yoshiyuki
    Ito, Chiharu
    Iimura, Osamu
    Tsunematsu, Sadao
    Watanabe, Yuko
    Kusano, Eiji
    Nagata, Daisuke
    DRUG TARGET INSIGHTS, 2014, 8 : 39 - 43
  • [3] Hyperuricemia and risk of heart failure: effect of chronic kidney disease
    Talib, S.
    Dehghan, A.
    Felix, J. F.
    Leening, M. J. G.
    Deckers, J. W.
    Hofman, A.
    Stricker, B. H. C. H.
    Witteman, J. C. M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 456 - 456
  • [4] Joint association of hyperuricemia and chronic kidney disease with mortality in patients with chronic heart failure
    Wang, Chi
    Che, Hebin
    Zhou, You
    Wang, Ruiqing
    Zhu, Di
    Cheng, Liting
    Rao, Chongyou
    Zhong, Qin
    Li, Zongren
    Duan, Yongjie
    Xu, Jiayu
    Dong, Wei
    Bai, Yongyi
    He, Kunlun
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [5] EFFECT OF FEBUXOSTAT VERSUS ALLOPURINOL ON HYPERURICEMIA AND PROGRESSION OF CHRONIC KIDNEY DISEASE
    Nagaraju, Shankar Prasad
    Attur, Ravindra Prabhu
    Rangaswamy, Dharshan
    Rao, Indu
    Rao, Srikanth Prasad
    Kaza, Sindhu
    Shenoy, Srinivas
    Saraf, Karan
    Bhojaraja, Mohan
    Ramaswamy, Ashok
    Laxminarayana, Sindhura Lakshmi Koulmane
    Kosuru, Srinivas
    Parthasarathy, Rajeevalochana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [6] The Effectiveness and Safety of Febuxostat for Chronic Kidney Disease Patients with Gout and Hyperuricemia
    Huang, Chien-Huei
    Wang, Ming-Cheng
    Yen, Chi-Tai
    Cheng, Ching-Lan
    Liu, Pheng-Ying Yeh
    Chang, Hui-Jen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 435 - 436
  • [7] Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
    Tsuruta, Yuki
    Mochizuki, Toshio
    Moriyama, Takahito
    Itabashi, Mitsuyo
    Takei, Takashi
    Tsuchiya, Ken
    Nitta, Kosaku
    CLINICAL RHEUMATOLOGY, 2014, 33 (11) : 1643 - 1648
  • [8] Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia
    Liao, Zhimin
    Xu, Lei
    Wan, Bo
    Wang, Liping
    Zhao, Chengzhi
    Wu, Gang
    Xie, Rui
    EMERGENCY MEDICINE INTERNATIONAL, 2022, 2022
  • [9] Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
    Yuki Tsuruta
    Toshio Mochizuki
    Takahito Moriyama
    Mitsuyo Itabashi
    Takashi Takei
    Ken Tsuchiya
    Kosaku Nitta
    Clinical Rheumatology, 2014, 33 : 1643 - 1648
  • [10] Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
    Nagaraju, Shankar Prasad
    Shenoy, Srinivas Vinayak
    Rao, Indu
    Prabhu, Ravindra Attur
    Rangaswamy, Dharshan
    Bhojaraja, Mohan V.
    Guddattu, Vasudeva
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2023, 34 (04) : 279 - 287
12345